
Dätwyler mit angepassten Zielwerten für 2022
Die geopolitischen Entwicklungen der vergangenen Monate haben die Inputkosten von Dätwyler an allen Standorten stark ansteigen lassen.
Die geopolitischen Entwicklungen der vergangenen Monate haben die Inputkosten von Dätwyler an allen Standorten stark ansteigen lassen.
Dätwyler hat den angekündigten Kauf von QSR am 13. Mai 2022 vollzogen und ist somit Eigentümerin des US-Unternehmens.
Der Dätwyler-Produktionsstandort Silao, Mexiko, ist das jüngste unserer Werke, das für die Produktion von Komponenten aus Flüssigsilikonkautschuk (Liquid Silicone Rubber, LSR) für unsere Kunden in Mexiko und ganz Nord- und Südamerika ausgebaut wurde.
Industry experts will discuss the benefits and challenges of transferring vaccines from vial applications to prefilled syringes, the components critical to the success of the vaccine products, and how to prepare your packaging toolbox for time-critical vaccine development and distribution.
Learn more about how the pharma industry is taking charge to improve environmental, social, and governance (ESG) critical issues.
Conference and exhibition featuring the leading XR companies and speakers and the best networking in XR. Discover more and visit us at booth #837.
Online presentations about "Detection of silicone oil on surface of rubber" by Simon Kervyn, Manager Surface Development and "X-ray irradiation as an alternative to gamma: effect on rubber properties" by Tine Hardeman, Manager Material Development. Discover more
Eugene Polini, Technical Key Account Manager at Datwyler examines the challenges drug developers are facing to speed up production lifecycles and what solutions are available to them.
Pharmaceutical Technology speaks to Katie Falcone, Scientific Support Manager at Datwyler, on important patient safety considerations in the world of parenteral packaging.
Datwyler’s Technical Key Account Manager, Eugene Polini, explains the drug development lifecycle and offers solutions for companies to better serve patient populations.
Datwyler's Commercial Development Manager, Jeff Smythe, speaks with European Pharmaceutical Manufacturer about what we learned from the pandemic and how we're preparing for the future.
For an injectable medicine, a switch in presentation from vials to prefilled syringes is a prime example of a drug delivery change that significantly improves the efficacy and appeal of a drug product. Read Pharmaceutical Technology's interview with Datwyler expert Eugene Polini to learn about how parenteral packaging plays a role in drug life cycle management strategies.